Pharmovital ApS: Financial statements 2025
CVR: 27206506
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Pharmovital ApS (CVR 27206506) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,379,629 and a net result of DKK 586,153 compared with DKK 1,153,281 the year before. That is a decrease of 21.2% compared with the year before. Equity in the 2025 report amounted to DKK 3,818,401. The solvency ratio was 49.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,379,629
- Profit/Loss
- DKK 586,153
- Equity
- DKK 3,818,401
- Total Assets
- DKK 7,784,706
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 2.4M | 586K | 3.8M | 2 |
| 2024 | - | 3M | 1.2M | 3.5M | 3 |
| 2023 | - | 2.9M | 1M | 2.6M | 3 |
| 2022 | - | 2.5M | 719K | 2.3M | 3 |
| 2021 | - | 1.1M | -772K | 1.9M | 3 |
Official annual report
How creditworthy is Pharmovital ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Pharmovital ApS
Pharmovital ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2003. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named GALLIVIT ApS and ApS KBIL 17 NR. 1578. The management consists of Kristian Krogh and Eskil Krogh. The company is owned by Eskro Holding ApS and Kr. Krogh Holding ApS. The company has 7 employees (2026). In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. Equity in the 2026 report amounted to DKK 8,743,173.